Tags: Chemical Compound, Chemical Substance.
Milacemide is a MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer’s disease. Early clinical trials however showed no positive results. The drug research now is abandoned.